Search results
Results from the WOW.Com Content Network
The COVID-19 pandemic in Iran has resulted in 7,627,863 [2] confirmed cases of COVID-19 and 146,837 [2] deaths. On 19 February 2020, Iran reported its first confirmed cases of infections in Qom. [5] The virus may have been brought to the country by a merchant from Qom who had travelled to China. [6]
Iran fully vaccinated almost 50 percent of the population by November 5th 2021, and permanently halted vaccine shot import. General population were to take the Sinopharm BIBP vaccine. [ 1 ] From December 2021 electronic vaccine certificate were mandatory for work, [ 2 ] [ 3 ] [ 4 ] mandatory service in Iranian Armed Forces , universities, and ...
The management of the COVID-19 crisis in Iran was made more complicated as a result of the sanctions consequences. [16] Human Rights Watch issued a statement on April 6, 2020, urging the US to ease sanctions against Iran so that Iran could have "access to crucial humanitarian resources during the [coronavirus] pandemic." [17]
In 2020-2021, amid the COVID-19 pandemic in Iran, Iran developed multiple COVID-19 vaccines [42] with five that have received emergency use authorization (COVIran Barekat, [43] Pasteurcovac, [44] FAKHRAVAC, [45] COVAX-19 [46] and Razi Cov Pars [47]). The new drugs launched in Iran for the treatment of MS include an interferon beta-1b by ...
[169] The impact of sanctions on Iran made the COVID-19 management a difficult issue in Iran. While enduring crippling sanctions, the healthcare system fought COVID-19 with a low budget and inadequately equipped facilities. [170] [171] In October 2020, Bloomberg reported that US sanctions had halted a flu vaccine shipment of 2 million doses.
A number of COVID-19 vaccines have been developed in China, which have been used in its vaccination programme and international vaccine diplomacy. Through November 2021, China was the world's largest exporter of COVID-19 vaccines, with a cumulative share of around 40% of worldwide exports (totalling around 1.5 billion doses), according to the ...
COVIran Barekat [3] (Persian: کووایران برکت) is a COVID-19 vaccine developed in Iran by Shifa Pharmed Industrial Group, a subsidiary of the Barkat Pharmaceutical Group. [4] [5] [6] It is an inactivated virus-based vaccine. [3] Iranian authorities have authorized its emergency use.
COVID-19 pandemic in Iran; 0–9. 4030 Call System; M. Mostaan 110; V. COVID-19 vaccination in Iran This page was last edited on 14 January 2021, at 01:13 (UTC). Text ...